342 related articles for article (PubMed ID: 35814615)
1. Optimization of Lipid Nanoformulations for Effective mRNA Delivery.
Chen H; Ren X; Xu S; Zhang D; Han T
Int J Nanomedicine; 2022; 17():2893-2905. PubMed ID: 35814615
[TBL] [Abstract][Full Text] [Related]
2. Exploration of mRNA nanoparticles based on DOTAP through optimization of the helper lipids.
Ma X; Wu F; Peng C; Chen H; Zhang D; Han T
Biotechnol J; 2023 Nov; 18(11):e2300123. PubMed ID: 37545293
[TBL] [Abstract][Full Text] [Related]
3. Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery.
Sun M; Dang UJ; Yuan Y; Psaras AM; Osipitan O; Brooks TA; Lu F; Di Pasqua AJ
AAPS PharmSciTech; 2022 May; 23(5):135. PubMed ID: 35534697
[TBL] [Abstract][Full Text] [Related]
4. Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection.
Lou G; Anderluzzi G; Schmidt ST; Woods S; Gallorini S; Brazzoli M; Giusti F; Ferlenghi I; Johnson RN; Roberts CW; O'Hagan DT; Baudner BC; Perrie Y
J Control Release; 2020 Sep; 325():370-379. PubMed ID: 32619745
[TBL] [Abstract][Full Text] [Related]
5. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
6. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of vein graft stenosis with a c-jun targeting DNAzyme in a cationic liposomal formulation containing 1,2-dioleoyl-3-trimethylammonium propane (DOTAP)/1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE).
Li Y; Bhindi R; Deng ZJ; Morton SW; Hammond PT; Khachigian LM
Int J Cardiol; 2013 Oct; 168(4):3659-64. PubMed ID: 23886527
[TBL] [Abstract][Full Text] [Related]
8. Electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by 4-heptadecyl-7-hydroxycoumarin.
Zuidam NJ; Barenholz Y
Biochim Biophys Acta; 1997 Oct; 1329(2):211-22. PubMed ID: 9371413
[TBL] [Abstract][Full Text] [Related]
9. Co-localization of fluorescent labeled lipid nanoparticles with specifically tagged subcellular compartments by single particle tracking at low nanoparticle to cell ratios.
Tiffany M; Szoka FC
J Drug Target; 2016 Nov; 24(9):857-864. PubMed ID: 27600702
[TBL] [Abstract][Full Text] [Related]
10. Peptide-based targeted polymeric nanoparticles for siRNA delivery.
Hussein WM; Cheong YS; Liu C; Liu G; Begum AA; Attallah MA; Moyle PM; Torchilin VP; Smith R; Toth I
Nanotechnology; 2019 Oct; 30(41):415604. PubMed ID: 31295734
[TBL] [Abstract][Full Text] [Related]
11. Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems.
Rezaee M; Oskuee RK; Nassirli H; Malaekeh-Nikouei B
J Control Release; 2016 Aug; 236():1-14. PubMed ID: 27317365
[TBL] [Abstract][Full Text] [Related]
12. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Lipid Types and Liposomal Formulations on Osteoblast Adiposity and Mineralization.
Chang SF; Yeh CC; Chen PJ; Chang HI
Molecules; 2018 Jan; 23(1):. PubMed ID: 29301300
[TBL] [Abstract][Full Text] [Related]
14. Analytical Characterization of Heterogeneities in mRNA-Lipid Nanoparticles Using Sucrose Density Gradient Ultracentrifugation.
Vaidya A; Parande D; Khadse N; Vargas-Montoya N; Agarwal V; Ortiz C; Ellis G; Kaushal N; Sarode A; Karve S; DeRosa F
Anal Chem; 2024 Apr; 96(14):5570-5579. PubMed ID: 38529613
[TBL] [Abstract][Full Text] [Related]
15. Optimization of lipid composition in cationic emulsion as in vitro and in vivo transfection agents.
Kim TW; Chung H; Kwon IC; Sung HC; Jeong SY
Pharm Res; 2001 Jan; 18(1):54-60. PubMed ID: 11336353
[TBL] [Abstract][Full Text] [Related]
16. Physico-chemical characterisation and transfection efficiency of lipid-based gene delivery complexes.
Birchall JC; Kellaway IW; Mills SN
Int J Pharm; 1999 Jun; 183(2):195-207. PubMed ID: 10361170
[TBL] [Abstract][Full Text] [Related]
17. Modulating Lipid Nanoparticles with Histidinamide-Conjugated Cholesterol for Improved Intracellular Delivery of mRNA.
Jung O; Jung HY; Thuy LT; Choi M; Kim S; Jeon HG; Yang J; Kim SM; Kim TD; Lee E; Kim Y; Choi JS
Adv Healthc Mater; 2024 Jun; 13(14):e2303857. PubMed ID: 38344923
[TBL] [Abstract][Full Text] [Related]
18. Liposome-mediated DNA immunisation via the subcutaneous route.
Perrie Y; McNeil S; Vangala A
J Drug Target; 2003; 11(8-10):555-63. PubMed ID: 15203925
[TBL] [Abstract][Full Text] [Related]
19. Effective induction of anti-tumor immunity using p5 HER-2/neu derived peptide encapsulated in fusogenic DOTAP cationic liposomes co-administrated with CpG-ODN.
Mansourian M; Badiee A; Jalali SA; Shariat S; Yazdani M; Amin M; Jaafari MR
Immunol Lett; 2014 Nov; 162(1 Pt A):87-93. PubMed ID: 25086399
[TBL] [Abstract][Full Text] [Related]
20. Hydration of lipoplexes commonly used in gene delivery: follow-up by laurdan fluorescence changes and quantification by differential scanning calorimetry.
Hirsch-Lerner D; Barenholz Y
Biochim Biophys Acta; 1999 Nov; 1461(1):47-57. PubMed ID: 10556487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]